Giurgea LT, Park JK, Walters KA, Scherler K, Cerva. The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine. NPJ Vaccines. 2021 Apr 6;6(1):48
Despite the importance of immunity against neuraminidase (NA), NA content and immunogenicity are neglected in current influenza vaccines. To address this, a recombinant N1/N2 NA vaccine (NAV) was developed. Stability assays were used to determine optimal temperature and buffer conditions for vaccine storage. The effect of divalent cation-related enhancement of NA stability and activity on N1 and N2 immunogenicity and efficacy against viral challenge was assessed. Differences in activity between N1 and N2 and cation-related activity enhancement did not translate into differences in immunogenicity or efficacy. NAV-vaccinated mice showed robust antibody titers against N1 and N2, and after challenge with influenza A (H1N1) virus, decreased viral titers and decreased antiviral and inflammatory responses by transcriptomic analysis. These findings provide guidance for optimal storage and assessment of NA-based vaccines and confirm the importance of NA in influenza vaccination strategies in attenuating viral replication and limiting inflammatory responses necessary to clear infection.
See Also:
Latest articles in those days:
- Duck CD8 + T Cell Response to H5N1 Highly Pathogenic Avian Influenza Virus Infection In Vivo and In Vitro 2 days ago
- Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong 2 days ago
- Understanding the rebound of influenza in the post COVID19 pandemic period holds important clues for epidemiology and control 4 days ago
- Evaluation of PCR-Based Hemagglutinin Subtyping as a Tool to aid in Surveillance of Avian Influenza viruses in Migratory Wild Birds 5 days ago
- Influenza virus NS1 interacts with 14-3-3ε to antagonize the production of RIG-I-mediated type I interferons 6 days ago
[Go Top] [Close Window]